The global omega-3 market is poised for remarkable growth, estimated at USD 4,362.2 million in 2025 and projected to reach USD 7,756.4 million by 2030, expanding at a CAGR of 12.2% during the forecast period. The surge in demand is fueled by growing consumer awareness of omega-3’s essential role in supporting cardiovascular, cognitive, eye, and joint health.
Unlike many nutrients, omega-3 fatty acids—particularly EPA and DHA—cannot be synthesized efficiently by the human body, making dietary supplements, fortified foods, and pharmaceutical-grade formulations critical sources of these essential fats. Their versatility allows incorporation into capsules, powders, beverages, and functional foods while maintaining stability and efficacy.
Fish oil, krill oil, and algal-based omega-3s remain the most widely used sources, with robust scientific evidence supporting their safety and effectiveness. As health-conscious consumers increasingly demand clean-label and sustainable nutrition, the omega-3 market is set for strong and sustained growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227
DHA Segment to Lead the Omega-3 Market Growth
Among various omega-3 types, docosahexaenoic acid (DHA) is expected to witness the fastest growth rate through 2030. DHA, a polyunsaturated omega-3 fatty acid (PUFA), serves as a key structural component in both the brain and eyes—making up 97% of total omega-3 fats in the brain and 93% in the retina.
Primary sources include fish, fish oils, dairy products, and specialty eggs, with salmon and tuna particularly rich in DHA (around 1.22–1.24 g per serving). Often referred to as 22:6(n-3), DHA is vital for cardiac tissue, neural development, and visual health.
Epidemiological studies have linked adequate DHA intake with a lower risk of Alzheimer’s disease and improved neural communication due to enhanced membrane fluidity. Its critical role in infant brain development and widespread use in nutritional supplements, functional foods, and infant nutrition make DHA the dominant segment within the omega-3 market.
Infant Formulas to Record the Highest CAGR
The infant formulas segment is expected to post the highest CAGR in the omega-3 market, driven by the increasing recognition of DHA’s essential role in early brain and eye development. Global health authorities, including the World Health Organization (WHO) and the European Food Safety Authority (EFSA), recommend DHA inclusion in infant nutrition.
With more working mothers and rising dependence on formula feeding, the demand for DHA- and EPA-fortified infant formulas has surged globally. Manufacturers are innovating with premium formulations that replicate the fatty acid profile of human breast milk.
The European Union’s regulatory mandate, since 2021, requiring DHA inclusion (20–50 mg/100 kcal) in all infant formula and follow-on formula products has accelerated market adoption. Growing preference for organic and clean-label formulas, combined with expanding birth rates and improved income levels in emerging economies, continues to boost segment growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227
Europe: A Leading Region in the Global Omega-3 Market
Europe is projected to hold a significant share of the global omega-3 market, supported by a robust regulatory framework, high consumer awareness, and a strong culture of preventive healthcare. European consumers exhibit a growing preference for premium, sustainable, and plant-based omega-3 products.
The rise of vegetarian and flexitarian diets in countries like Germany, the UK, and France is driving demand for algal-derived omega-3 alternatives. Key regional players—such as Pelagia AS (Norway), Corbion (Netherlands), and DSM-Firmenich (Netherlands)—are investing heavily in product innovation and capacity expansion.
For instance, Corbion recently launched its AlgaVia omega-3 product line, while Pelagia AS expanded its omega-3 concentrate production facilities. Moreover, the European Society of Cardiology (ESC) emphasizes omega-3’s cardiovascular benefits, further promoting consumer uptake.
Companies like BASF SE (Germany), Aker BioMarine (Norway), and Croda International (UK) are developing advanced delivery systems such as microencapsulated omega-3 powders for enhanced stability and shelf life. Compliance with EU standards and growing consumer trust in certified products are expected to maintain Europe’s dominance in the global market.
Leading Omega-3 Companies:
The global omega-3 market features several leading companies driving innovation and expansion, including:
BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), Golden Omega (Chile), Polaris (France), BTSA (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).
These players are focusing on sustainable sourcing, scientific validation, and advanced formulations to meet the evolving global demand for omega-3 products.
Conclusion: Omega-3s Powering the Future of Preventive Nutrition
As global consumers increasingly prioritize health, wellness, and sustainability, the omega-3 market stands at the forefront of nutritional innovation. With expanding applications across dietary supplements, functional foods, infant nutrition, and pharmaceuticals, omega-3 fatty acids are set to play a pivotal role in the next decade of preventive healthcare and wellness.
